-
Something wrong with this record ?
Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides
B. Servusova-Vanaskova, P. Paterova, V. Garaj, J. Mandikova, J. Kunes, L. Naesens, P. Jílek, M. Dolezal, J. Zitko,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13346
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2006-01-01 to 1 year ago
PubMed
25676890
DOI
10.1111/cbdd.12536
Knihovny.cz E-resources
- MeSH
- Antifungal Agents chemistry pharmacology MeSH
- Anti-Infective Agents chemical synthesis chemistry pharmacology MeSH
- Antitubercular Agents chemical synthesis chemistry pharmacology MeSH
- Cell Line drug effects MeSH
- Humans MeSH
- Methicillin-Resistant Staphylococcus aureus drug effects MeSH
- Microbial Sensitivity Tests MeSH
- Mycobacterium tuberculosis drug effects MeSH
- Drug Evaluation, Preclinical methods MeSH
- Molecular Docking Simulation MeSH
- Chemistry Techniques, Synthetic MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
This work presents synthesis and antimicrobial evaluation of nineteen 6-alkylamino-N-phenylpyrazine-2-carboxamides. Antimycobacterial activity was determined against Mycobacterium tuberculosis H37Rv, M. kansasii and two strains of M. avium. Generally, the antimycobacterial activity increased with prolongation of simple alkyl chain and culminated in compounds with heptylamino substitution (3e, 4e) with MIC = 5-10 μm against M. tuberculosis H37Rv. On the contrary, derivatives with modified alkyl chain (containing e.g. terminal methoxy or hydroxy group) as well as phenylalkylamino derivatives were mainly inactive. The most active compounds (with hexyl to octylamino substitution) were evaluated for their in vitro activity against drug-resistant strains of M. tuberculosis and possessed activity comparable to that of the reference drug isoniazid. None of the tested compounds were active against M. avium. Some derivatives exhibited activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (best MIC = 7.8 μm), while Gram-negative strains as well as tested fungal strains were completely unsusceptible. Active compounds were tested for in vitro toxicity on various cell lines and in most cases were non-toxic up to 100 μm.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16028489
- 003
- CZ-PrNML
- 005
- 20181212144211.0
- 007
- ta
- 008
- 161005s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cbdd.12536 $2 doi
- 024 7_
- $a 10.1111/cbdd.12536 $2 doi
- 035 __
- $a (PubMed)25676890
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Servusová, Barbora $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0230435
- 245 10
- $a Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides / $c B. Servusova-Vanaskova, P. Paterova, V. Garaj, J. Mandikova, J. Kunes, L. Naesens, P. Jílek, M. Dolezal, J. Zitko,
- 520 9_
- $a This work presents synthesis and antimicrobial evaluation of nineteen 6-alkylamino-N-phenylpyrazine-2-carboxamides. Antimycobacterial activity was determined against Mycobacterium tuberculosis H37Rv, M. kansasii and two strains of M. avium. Generally, the antimycobacterial activity increased with prolongation of simple alkyl chain and culminated in compounds with heptylamino substitution (3e, 4e) with MIC = 5-10 μm against M. tuberculosis H37Rv. On the contrary, derivatives with modified alkyl chain (containing e.g. terminal methoxy or hydroxy group) as well as phenylalkylamino derivatives were mainly inactive. The most active compounds (with hexyl to octylamino substitution) were evaluated for their in vitro activity against drug-resistant strains of M. tuberculosis and possessed activity comparable to that of the reference drug isoniazid. None of the tested compounds were active against M. avium. Some derivatives exhibited activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (best MIC = 7.8 μm), while Gram-negative strains as well as tested fungal strains were completely unsusceptible. Active compounds were tested for in vitro toxicity on various cell lines and in most cases were non-toxic up to 100 μm.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiinfekční látky $x chemická syntéza $x chemie $x farmakologie $7 D000890
- 650 _2
- $a antifungální látky $x chemie $x farmakologie $7 D000935
- 650 _2
- $a antituberkulotika $x chemická syntéza $x chemie $x farmakologie $7 D000995
- 650 _2
- $a buněčné linie $x účinky léků $7 D002460
- 650 _2
- $a techniky syntetické chemie $7 D060326
- 650 _2
- $a preklinické hodnocení léčiv $x metody $7 D004353
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $7 D009169
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Paterová, Pavla $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. Department of Clinical Microbiology, University Hospital Hradec Králové, Sokolská 581, Hradec Králové, 500 05, Czech Republic. $7 xx0138094
- 700 1_
- $a Garaj, Vladimír $u Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojárov 10, Bratislava, 832 32, Slovakia. $7 _AN038040
- 700 1_
- $a Mandíková, Jana $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0159490
- 700 1_
- $a Kuneš, Jiří, $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $d 1965- $7 xx0105105
- 700 1_
- $a Naesens, Lieve $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven, 3000, Belgium.
- 700 1_
- $a Jílek, Petr $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 mzk2002156737
- 700 1_
- $a Doležal, Martin, $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $d 1961- $7 jn19981000714
- 700 1_
- $a Zitko, Jan. $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0230408
- 773 0_
- $w MED00173265 $t Chemical biology & drug design $x 1747-0285 $g Roč. 86, č. 4 (2015), s. 674-681
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25676890 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20181212144335 $b ABA008
- 999 __
- $a ok $b bmc $g 1166803 $s 953119
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 86 $c 4 $d 674-681 $e 20150306 $i 1747-0285 $m Chemical biology & drug design $n Chem Biol Drug Des $x MED00173265
- GRA __
- $a NT13346 $p MZ0
- LZP __
- $a Pubmed-20161005